Clinical Trial Update: Long-Term Follow-up Safety Study of Human Central Nervous System Stem Cells in Subjects With Geographic Atrophy of Age-Related Macular Degeneration

View source ↗

Summary

Long-term follow-up safety study of human central nervous system stem cells in geographic atrophy due to age-related macular degeneration has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Geographic Atrophy

Drugs mentioned

• human central nervous system stem cells (hCNS-SC) (human central nervous system stem cells)

Snippet

Sponsor: StemCells, Inc. | Conditions: Age-Related Macular Degeneration, Geographic Atrophy | Status: TERMINATED